Furthermore, it is demonstrated that when ITGB1 is overexpressed and overactivated in cancer, such as in lung, colorectal, pancreatic and breast carcinoma it is also associated with a poor prognosis13–16. This evidence concerns the gene ITGB1 and cancer.